Strand Therapeutics
mRNA therapy developer using genetic circuits for targeted cancer and immune system activation
Funding
$266.03M
2025
Details
Headquarters
Boston, United States
CEO
Jake Becraft, Ph.D.
Website
Milestones
FOUNDING YEAR
2017
Listed In
News
The latest coverage and announcements from Strand Therapeutics.